Please login to the form below
Lilly appoints Philip Johnson to senior VP and treasurer
He currently serves as VP, investor relations at the pharma company
Eli Lilly and Company has appointed Philip Johnson to be its senior vice president, finance and treasure from January 1 2018.
He will report to Joshua Smiley, who will become senior vice president and chief financial officer from the same date.
He said: “Phil has been a trusted partner for our shareholders, effectively communicating the company’s results and expectations, while ensuring management’s actions are informed by shareholder input.
“With his external focus and experience in the capital markets, Phil is an ideal candidate to assume this important position and to help guide Lilly’s financial strategy.”
Johnson has been with Lilly for 22 years, serving in a variety of financial roles in the US and overseas.
He has served as vice president for investor relations since 2007, and before that he was vice president, finance and chief financial officer for global manufacturing and quality.
Featured jobs
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Virgo Health
Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
